Converging AI, autonomy, and secure communications push MUM-T from experimentation to scalable deployment LONDON, Feb. 7, 2026 /PRNewswire/ — According to a new Frost & Sullivan analysis, Human-Machine Integration/Manned–Unmanned Teaming (MUM-T), Global, 2025–2027, the rapid convergence of artificial intelligence, autonomy, and secure networked communications is transforming modern military doctrine and accelerating the shift toward multi-domain […]
Category Archives: Pr Newswire
Research Introduces 577 Epigenetic Mechanism for Asian Skin SHANGHAI, Feb. 7, 2026 /PRNewswire/ — The IMCAS World Congress 2026, an internationally recognized forum for aesthetic medicine and clinical research, opened on January 31 in Paris. As a global platform supporting collaboration in dermatology, plastic surgery, and aging science, IMCAS facilitates the exchange of interdisciplinary research and clinical […]
PHocus enrollment completed in under 12 months from first patient dosed, representing a rapid enrollment pace in pulmonary hypertension associated with interstitial lung disease Topline results on track for second half of calendar year 2026 WALTHAM, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) — Pulmovant, a clinical-stage biotechnology company committed to transforming the lives of patients […]
IMVT-1402 potentially registrational trial in difficult-to-treat rheumatoid arthritis (D2T RA) fully enrolled, with topline data expected in the second half of calendar year 2026; topline data from the proof-of-concept trial in cutaneous lupus erythematosus (CLE) expected in the second half of calendar year 2026 IMVT-1402 development is progressing with potentially registrational studies in Graves’ disease […]
Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (Δ 21.6 P<0.0001) All brepocitinib 45 mg patients achieved a clinically meaningful response, with 100% demonstrating at least a 10-point improvement on CSAMI-A On the Investigator’s Global Assessment (IGA), 69% […]
Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (Δ21.6 P<0.0001). Brepocitinib demonstrated rapid, deep and sustained improvements across all other efficacy endpoints measured with consistent safety profile Priovant plans to progress CS to a pivotal program with a […]
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Feb. 06, 2026 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; SEHK:13) will be announcing its final results for the year ended December 31, 2025 on Thursday, March 5, 2026 at 6:00 am Eastern Standard Time (EST) / 11:00 am Greenwich Mean Time (GMT) / 7:00 pm Hong Kong […]
SHANGHAI, Feb. 6, 2026 /PRNewswire/ — Lanvin Group (NYSE: LANV) today announced that it has completed the sale of Caruso, a luxury Italian menswear manufacturer and brand, to MondeVita Italy S.r.l., a subsidiary of Mondevo Group. The transaction reflects Lanvin Group’s commitment to focus on the sustainable development of heartland brands. For Mondevo Group, the acquisition […]
CHENNAI, India, Feb. 6, 2026 /PRNewswire/ — India’s top-ranked higher education, the Indian Institute of Technology Madras (IIT Madras), has established a new entity, IIT Madras Global Research Foundation (IITM Global) with a charter to take IIT Madras’ research and innovation ecosystem into multiple geographies. Indian External Affairs Minister Dr S Jaishankar (3rd L) releases […]
Sun Life and charity partner join hands to bounce into the Chinese New Year and connect the community through joy Over 1,000 gift vouchers distributed in celebration of Sun Life’s milestone as it looks ahead to its 135th anniversary in Hong Kong HONG KONG, Feb. 6, 2026 /PRNewswire/ — The “Sun Life ‘The Big Bounce’ World Tour – […]
